华熙生物：关于持股5%以上股东权益变动触及5%刻度的提示性公告

Core Viewpoint - Huaxi Bio announced a shareholding change involving its major shareholder Guoshou Chengda, which will not trigger a mandatory takeover bid and will not alter the control of the company [2] Group 1: Shareholding Change - Guoshou Chengda plans to reduce its shareholding as per the announcement made on November 5, 2025, regarding the share reduction plan [2] - After the shareholding change, Guoshou Chengda will hold 24,083,913 shares, representing approximately 5.00% of the total share capital of Huaxi Bio [2] - Guoshou Chengda does not have any concerted action parties, ensuring that the control structure of the company remains unchanged [2]